Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

21.34
-1.1200-4.99%
Post-market: 21.610.2700+1.27%19:59 EDT
Volume:26.40M
Turnover:569.52M
Market Cap:4.86B
PE:41.66
High:22.30
Open:22.21
Low:21.09
Close:22.46
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.86
T/O Rate:13.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:8.98
PE(LYR):41.66

Loading ...

Hims & Hers Health Shares up 3% Premarket After Q3 Revenue Beat

THOMSON REUTERS
·
Nov 04, 2025

Hims & Hers Stock (HIMS) Pops on Talks to Offer Novo Nordisk’s Wegovy

TIPRANKS
·
Nov 04, 2025

24H|Palantir Drops 4%; Navitas Tumbles 12%; HIMS up 5%; Baidu Jumps 6%; iHeartMedia Soars 55%; Nuclear Stocks Fall, Energy Fuels down 6%; BWXT down 5%

Tiger Newspress
·
Nov 04, 2025

Stock Track | Hims & Hers Health Soars 5.45% on Strong Q3 Results and Potential Wegovy Partnership

Stock Track
·
Nov 04, 2025

Hims & Hers Health Exec Says Investments May Result in Temporary Pause in Year Over Year Margin Expansion - Conf Call

THOMSON REUTERS
·
Nov 04, 2025

Hims & Hers Stock Pops After Q3 Earnings: Here's Why

Benzinga
·
Nov 04, 2025

Stock Track | Hims & Hers Health Soars 6.65% After Hours on Strong Q3 Results and Wegovy Partnership Talks

Stock Track
·
Nov 04, 2025

Hims Shares Rise in After-Market Trade Following Results, Last up 5.6% at $46.84

THOMSON REUTERS
·
Nov 04, 2025

Telehealth provider Hims & Hers beats Q3 revenue expectations

Reuters
·
Nov 04, 2025

Hims And Hers Beats Revenue Estimates On Strong Subscriber Growth

Reuters
·
Nov 04, 2025

Earnings Flash (HIMS) Hims & Hers Health Posts Q3 EPS $0.06, vs. FactSet Est of $0.09

MT Newswires Live
·
Nov 04, 2025

Hims & Hers Health Q3 EPS $0.06 Misses $0.09 Estimate, Sales $598.976M Beat $580.241M Estimate

Benzinga
·
Nov 04, 2025

BRIEF-Hims & Hers Health Q3 Revenue USD 600 Million Vs. IBES Estimate USD 579.3 Million

Reuters
·
Nov 04, 2025

Hims & Hers Health Q3 EPS USD 0.06

THOMSON REUTERS
·
Nov 04, 2025

Hims & Hers Health Outlook FY Adjusted Ebitda USD 307-317 Million

THOMSON REUTERS
·
Nov 04, 2025

Hims & Hers Health - Outlook Q4 Revenue $605 Million to $625 Million

THOMSON REUTERS
·
Nov 04, 2025

Hims & Hers Health - Are in Active Discussions to Make Wegovy Injections and Novo Nordisk's Oral Wegovy Available Through Hims & Hers Platform

THOMSON REUTERS
·
Nov 04, 2025

BUZZ-PREVIEW: Hims & Hers dips; focus on weigth-loss drug

Reuters
·
Nov 04, 2025

24H|Big Tech Stocks Rise with Palantir up 2%, Nvidia, Meta, AMD up 1%; Medical AI Stocks Jump, AIFF up 6%, HIMS up 3%; Drone-Related Stocks Rally, Palladyne AI up 8%, SES AI up 6%

Tiger Newspress
·
Nov 03, 2025

Bullish flow in Hims and Hers Health with shares up 3.2%

TIPRANKS
·
Nov 01, 2025